Notice: YODA-KY is in the process of changing its English company name to Dasher Neuroscience.
Welcome to Dasher Neuroscience
Pioneering AI-Driven Neuroscience Solutions
Dasher Neuroscience is harnessing artificial intelligence (AI) to develop transformative therapies for CNS disorders, tackling unmet medical needs and bringing hope to patients worldwide.
Transforming
Neurodegenerative
Disease Treatment with AI
Precision
Therapies
AI-Powered
Discovery
Accelerated
Development
Innovative Pipeline for MSA,
Parkinson’s, Alzheimer’s and Schizophrenia
YA-101: Orphan Drug for Multiple System Atrophy (MSA)
FDA Fast Track and Orphan Drug Designations in US, EU & Japan
Phase II trials in U.S., Japan and Taiwan
Expanding Our Pipeline
Parkinson’s
Alzheimer’s
Schizophrenia
“ Addressing critical unmet needs in neuroscience ”
Our Mission,
Bringing Innovative Therapies to Patients Worldwide
Driven by innovation and patient focus, Dasher Neuroscience is dedicated to developing life-changing CNS therapies that improve lives worldwide.